Clinical Trials Browser

Active not recruiting × INDUSTRY × soluble LAG-3 protein, human × Clear all

NCT06726265 2026-03-18

Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004)

Phase 3 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT05747794 2024-12-17

AIPAC-003

Phase 2/3 Active not recruiting

Breast Neoplasms